We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Pfizer Inc | LSE:0Q1N | London | Ordinary Share | PFIZER ORD (CDI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| -0.55 | -2.11% | 25.55 | 24.80 | 26.30 |
| High Price | Low Price | Open Price | Shares Traded | Last Trade |
|---|---|---|---|---|
| 156,252 | 16:35:17 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 58.5B | 2.12B | 0.3753 | 67.31 | 142.63B |
| Date | Time | Source | Headline |
|---|---|---|---|
| 23/4/2024 | 06:27 | ALNC |  Moderna, Pfizer/BioNTech set for UK court clash over Covid jab patents |
| 09/4/2024 | 18:41 | ALNC | Pfizer RSV treatment meets targets in trial of adults under age 60 |
| 21/3/2024 | 16:29 | ALNC | TOP NEWS: Haleon buys back shares worth GBP315 million from Pfizer |
| 19/3/2024 | 10:17 | ALNC | Haleon to buy back shares from Pfizer for GBP315 million |
| 18/3/2024 | 08:47 | ALNC | TOP NEWS: Pfizer launches GBP2 billion sale of 8% stake in Haleon |
| 13/3/2024 | 16:28 | ALNC | IN BRIEF: EU approves Pfizer's Prevenar in children with pneumococcal |
| 01/3/2024 | 18:27 | ALNC | Pfizer targets eight blockbuster drugs by 2030 in new oncology plan |
| 30/1/2024 | 12:56 | ALNC | TOP NEWS: Pfizer backs outlook but 2023 profit falls after Covid boost |
| 29/1/2024 | 08:26 | ALNC | Astellas and Pfizer's Padcev validated by EMA to treat bladder cancer |
| 09/1/2024 | 13:49 | ALNC | Pfizer's licence application accepted for priority review of Tivdak |
1 Year Pfizer Chart |
Intraday Pfizer Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
